FDA OKs Cresemba, Astellas drug for rare but serious fungal infections, after priority review
March 06, 2015 at 15:02 PM EST
The Food and Drug Administration has approved a new antifungal drug, Cresemba, to treat two rare but serious infections that typically strike people with weakened immune systems.
